| http://www.w3.org/ns/prov#value | - The kind of developmental reprogramming we see from this work could represent an important determinate of risk in people genetically susceptible to hormone-dependent tumors, such as uterine, breast and prostate cancer, says the study's principal investigator, Cheryl Walker, ...GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug...a key patent covering t
|
